待处理
入排:待复核
图源:待检查
入排置信度 0.00
BEAT-SC: randomized, controlled, double-blind phase III study of bevacizumab plus atezolizumab and chemotherapy as first-line treatment of extensive-stage small cell lung cancer.
Makoto Nishio, Nobuyuki Yamamoto, Yuichiro Ohe, Satoshi Watanabe, Xiubao Ren, Shuji Murakami, Nong Yang, Yasuto Yoneshima, Gaofeng Li, Nobuyuki Katakami, Xianling Liu, Shoichiro Yamamoto, Yuki Nakagawa, Morihiko Hayashi, Chunyu Qian, Toshihiro Nanki, Baohui Han
J Immunother Cancer 14(11) e014519
入排依据:未可靠识别 OS/PFS/DFS/EFS/RFS/TTP、Kaplan-Meier、HR 或其他 time-to-event 结局,需复核。
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板